JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buettner, C.
Right arrow Articles by Berry, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buettner, C.
Right arrow Articles by Berry, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 31, 21598-21602, July 30, 1999


The Caenorhabditis elegans Homologue of Thioredoxin Reductase Contains a Selenocysteine Insertion Sequence (SECIS) Element That Differs from Mammalian SECIS Elements but Directs Selenocysteine Incorporation*

Christoph Buettner, John W. Harney, and Marla J. BerryDagger

From the Thyroid Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115.

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Thioredoxin reductases (TRR) serve critical roles in maintaining cellular redox states. Two isoforms of TRR have been identified in mammals: both contain a penultimate selenocysteine residue that is essential for catalytic activity. A search of the genome of the invertebrate, Caenorhabditis elegans, reveals a gene highly homologous to mammalian TRR, with a TGA selenocysteine codon at the corresponding position. A selenocysteyl-tRNA was identified in this organism several years ago, but no selenoproteins have been identified experimentally. Herein we report the first identification of a C. elegans selenoprotein. By 75Se labeling of C. elegans, one major band was identified, which migrated with the predicted mobility of the C. elegans TRR homologue. Western analysis with an antibody against human TRR provides strong evidence for identification of the C. elegans selenoprotein as a member of the TRR family. The 3'-untranslated region of this gene contains a selenocysteine insertion sequence (SECIS) element that deviates at one position from the previously invariant consensus "AUGA." Nonetheless, this element functions to direct selenocysteine incorporation in mammalian cells, suggesting conservation of the factors recognizing SECIS elements from worm to man.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The synthesis of selenoproteins requires several specialized components of the translational machinery (reviewed in Ref. 1). In addition to tRNASec and the enzymes necessary for generation of charged selenocysteyl-tRNASec, this process requires a selenocysteine specific elongation factor, SelB, identified so far only in prokaryotes. Specific secondary structures in the mRNAs of selenoproteins are required to distinguish UGA selenocysteine codons from stop codons. These structures, termed selenocysteine insertion sequence (SECIS)1 elements, are located adjacent to the UGA codons in prokaryotes and in the 3'-UTR of selenoprotein mRNAs in eukaryotes (2). Eukaryotic SECIS elements are characterized by a small number of conserved nucleotides at specific positions in the stem-loop. These are foremost, the invariable sequence motif "AUGA," which pairs with "GA" opposite each other on the 5' and 3' arms of the stem, respectively, and two or three adenosines in either the terminal loop or an internal bulge. In all vertebrate selenoprotein mRNAs identified to date these sequences are highly conserved. Mutagenesis studies have shown that the conserved nucleotides and secondary structural features are necessary to suppress the stop codon function of a UGA codon and to decode it as selenocysteine (3, 4).

The ability to synthesize selenoproteins is of fundamental importance in mammals, as deletion of the gene for selenocysteyl-tRNA leads to an embryonic lethal phenotype in a mouse model (5). The selenoprotein or proteins responsible for this lethality have not been determined. Cytoplasmic glutathione peroxidase, a selenoprotein functioning in breakdown of toxic hydroperoxides, appears not to be critical for normal development of mammals, probably due to redundancy in the glutathione peroxidase gene family (6). Among the 13 eukaryotic selenoproteins identified to date, thioredoxin reductase (TRR) is a strong candidate for an essential selenoprotein. TRR is a disulfide oxidoreductase with a broad substrate specificity; it reduces among many other substrates the active site disulfide in oxidized thioredoxin. Thioredoxin (TR) is an important cofactor in a large number of biological processes. While a knockout model for TRR has not been reported to date, targeted disruption of the TR gene causes early embryonic lethality, and TRR is the only known reductant of TR (7).

Two TRR isoforms have been described in several mammalian species, both of which contain a UGA codon encoding selenocysteine as the penultimate C-terminal amino acid (8-12). Putative SECIS elements are present in the 3'-UTRs of both sequences. In contrast to other selenoenzymes, it has been proposed that the selenocysteine residues in the TRRs are not in the predicted catalytic site, but function to carry reducing equivalents from the active site to substrates (13). Nonetheless, selenocysteine is critical for reducing thioredoxin, as demonstrated by the loss of activity upon chemical alteration (14) or proteolytic removal of this amino acid (13).

The C. elegans gene for selenocysteyl-tRNA was identified by Lee et al. in 1990 (15), indicating that selenoprotein genes would likely be present. To date, no selenoproteins have been experimentally identified in C. elegans. Since the complete genome of C. elegans has been sequenced, and this organism is amenable to genetic studies, it promises to be a valuable model system for the study of eukaryotic selenoprotein synthesis. In this study, we show that C. elegans expresses at least one selenoprotein. This protein migrates with the predicted size of a thioredoxin reductase homologue in the C. elegans sequence data base. We further show that the selenium-labeled protein reacts in Western blotting analysis with an antibody prepared against a human TRR peptide, providing evidence for its identification as a TRR homologue. Finally, we report identification and characterization of a functional SECIS element in the 3'UTR of the C. elegans TRR gene. This SECIS element deviates at a previously invariant position from all vertebrate SECIS elements reported to date, but functions to direct selenocysteine incorporation in a mammalian cell line.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

75Se Labeling of C. elegans-- C. elegans strain bristol (N2) was used throughout these studies (16). For 75Se labeling of worms, their food source, Escherichia coli strain OP50, was grown overnight in 1 ml of Luria broth medium containing 20 µCi of 75Se. 75Se-labeled bacteria were harvested by pelleting, resuspended in M9 buffer (22 mM KH2PO4, 42 mM Na2HPO4, 85 mM NaCl, 1 mM MgSO4), and dispensed on 60-mm plates containing 3 ml of nematode growth medium agar. Worms were grown at 22 °C on lawns of 75Se-labeled E. coli and harvested by washing them off the plates in M9 buffer, followed by sedimentation at 800 × g for 5 min and three washes in M9 buffer. The pellets were resuspended in phosphate-buffered saline and sonicated. As a protease inhibitor 1 mM phenylmethylsulfonyl fluoride was added. Lysates were stored at -20 °C until further use.

Sequences of Genes and cDNAs from C. elegans-- All of the predicted protein sequences were first identified in the genomic sequences generated by the C. elegans Genome Sequencing Consortium. The TBLASTN algorithm was run against the Washington University Genome Sequencing Center C. elegans data base to identify sequences that encode proteins with homology to mammalian selenoproteins. We identified a gene with 71% sequence similarity to human (h)TRR (GenBankTM accession number 2500117). This sequence was used to search the GenBankTM expressed sequence tag data base and led to the identification of the cDNA clone yk384f6 (provided by Y. Kohara, National Institute of Genetics, Mishima, Japan). The cDNA sequence of yk384f6 was determined by automated sequencing (Applied Biosystems, Foster City, CA). The sequence of this cDNA clone confirmed the predicted intron/exon junctions.

RNA Isolation and 3'-Rapid Amplification of cDNA Ends-- Total RNA was isolated from mixed stage populations of C. elegans. Worms were first ground into a fine powder using a liquid nitrogen-cooled mortar and pestle. Powdered C. elegans (200 mg) were homogenized in 2 ml of TRIzol (Life Technologies, Inc.). RNA was collected from the aqueous phase following the addition of chloroform, precipitated by adding isopropyl alcohol, and air-dried. First strand cDNA was synthesized by reverse transcriptase using oligo(dT) as primer and used as template in PCR with primers flanking the predicted start and stop codon. The PCR product was sequenced with primer CB 122 (see below) by automated sequencing.

Constructs-- The minimal SECIS element of TRR was generated by PCR using the overlapping primers CB122 (CCAAGCTTTAGGCGGGTGACGACCTTTGGCTAAACT) and CB124 (GGGCGGCCGCCATCAGACCAGAGGCGCTCACGATGG). The mutant SECIS element (for construct 151) was generated using primer CB123, CCAAGCTTTAGGCGGGTAACGACCTTTGGCTAAACT (mutation indicated in bold). Constructs 150 (wild type SECIS) and 151 (mutant SECIS) were derived by subcloning the PCR fragments (via HindIII and NotI) into a construct expressing rat D1 (G16D10Delta H3), substituting the TRR SECIS element for that of rat D1 (4). Sequences were confirmed by automated sequencing.

DNA Transfections and 5'-Deiodinase Assays-- All constructs were cotransfected with plasmid pTKGH, a thymidine kinase promoter-directed human growth hormone-expressing plasmid, into HEK-293 cells by calcium phosphate precipitation as described previously (17). Transfection efficiencies were monitored by assay of human growth hormone in the media. Cell sonicates were assayed for the presence of 5' deiodinase activity as described previously (18). Deiodinase activities were calculated per microliter of cell sonicate and normalized to amount of growth hormone secreted into the media.

Electrophoresis and Immunoblot Analyses-- Typically 200 µg of crude 75Se-labeled C. elegans homogenate was combined with 5× SDS-PAGE sample buffer (0.3125 M Tris-HCl, 4% beta -mercaptoethanol, 50% glycerol, 0.5 mg/ml bromphenol blue, pH 8.3) and heated for 5 min at 100 °C. Samples were subjected to SDS-PAGE analysis on 10% polyacrylamide gels (acrylamide:bis, 37.5:1), followed by electrotransfer to Immobilon (Millipore) in 20% methanol, 25 mM Tris-HCl, pH 8.3, 192 mM glycine. Membranes were blocked with 5% (w/v) nonfat milk in TBS-Tween (20 mM Tris-HCl, pH 7.6, 140 mM NaCl, 0.1% Tween 20), incubated with antibody 2098 (generous gift of John Gasdaska), at 1:200 dilution in 1.25% (w/v) nonfat milk in TBS-Tween, followed by incubation with peroxidase-conjugated secondary antibody (NEN Life Science Products). Reaction products were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech) and exposure to X-Omat film (Eastman Kodak Co.). After extensive washing of the membrane and decay of the chemiluminescent signal, the membrane was subjected to autoradiography for 7 days.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of Selenoproteins in C. elegans-- To identify selenoproteins in C. elegans, we developed a 75Se labeling technique based on their food source, bacteria. E. coli were cultured in Luria broth media containing 75Se. This led to incorporation of 75Se predominantly into two E. coli selenoproteins. Worms were allowed to feed on a lawn of 75Se-labeled bacterial for 24 h, until bacteria were depleted, then harvested for analysis of 75Se incorporation. Since there are always trace amounts of bacteria in the gut of C. elegans, we also prepared a lysate of the 75Se-labeled bacteria. SDS-PAGE analysis of C. elegans homogenate reveals three major selenoprotein bands, two in the 80-95 kDa size range and one of ~58 kDa. The two upper bands are also present in the bacterial lysate and correspond in size to the isoforms of bacterial formate dehydrogenases (19). The most prominent selenoprotein in C. elegans, which is not found in the bacterial lysate, is the 58-kDa protein (Fig. 1). Thus, the 58-kDa band likely represents a C. elegans selenoprotein. In control experiments we treated the C. elegans lysate with RNase A. No difference in labeling pattern was seen compared with the untreated lysate, suggesting that none of the bands visible by autoradiography are of RNA origin (data not shown).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   75Se labeling of worms and bacteria. C. elegans were fed 75Se-labeled bacteria as food source, homogenized, and subjected to SDS-PAGE analysis, followed by autoradiography. Note that the upper two bands in the 80-95 kDa range seen in C. elegans are also present in the E. coli lane and are thus most likely of bacterial origin. The major band not found in E. coli migrates with a molecular mass of ~58 kDa.

TRR Is the Only Eukaryotic Selenoprotein Homologue in C. elegans with a UGA Selenocysteine Codon-- We performed a search of the C. elegans genome data base with the sequences of all known mammalian selenoproteins. This search revealed a gene highly homologous to mammalian TRR, with a TGA selenocysteine codon at the corresponding position (Fig. 2, GenBankTM accession number 1397273). No homologues of any of the three isoforms of the iodothyronine deiodinases, selenoprotein P, or selenoprotein W were found. Homologues of glutathione peroxidases, selenophosphate synthetase (Sps2), and a 15-kDa selenoprotein (20) are present, but each contains a cysteine codon in place of the TGA selenocysteine codon found in the corresponding mammalian gene. Thus, the C. elegans thioredoxin reductase is the only homologue of a known mammalian selenoprotein containing a conserved selenocysteine codon.


View larger version (110K):
[in this window]
[in a new window]
 
Fig. 2.   Alignment of the C. elegans thioredoxin reductase, human thioredoxin reductase, and C. elegans glutathione reductase protein sequences. The alignment shows the conserved region around the selenocysteine and the N-terminal extension. The peptide sequence to which the human TRR antiserum was raised is marked by a line. Note the high homology in this region between the C. elegans and human TRR sequences.

Assignment of the 58-kDa Selenoprotein as a Member of the TRR Family-- To obtain evidence for the identity of the 75Se-labeled 58-kDa protein as a thioredoxin reductase-like protein, we performed Western analysis using a polyclonal antibody against human TRR. The antibody was raised against an hTRR peptide sequence, which shares 17 of 21 amino acids (81% identity) with the corresponding C. elegans sequence (Fig. 2) and thus might be predicted to cross-react with the worm protein. Western analysis of the 75Se-labeled C. elegans lysate revealed an antibody-reactive protein of the predicted size (Fig. 3, hTRR antibody) and two additional cross-reacting bands. After extensive washing of the membrane and decay of the chemiluminescent signal, we used autoradiography to visualize the 75Se-labeled band. Superimposing the autoradiograph and chemiluminescence film revealed that the C. elegans-specific 58-kDa 75Se-labeled band and one of the three Western blot bands comigrated precisely (Fig. 3, 75Se labeling), providing strong evidence for identification of the 75Se-labeled band as a TRR homologue. The presence of additional cross-reacting bands prompted us to further examine the C. elegans data base for other sequences bearing homology to the human TRR peptide. After TRR, the next highest scoring matches were the glutathione reductase (GR) sequence and an uncharacterized pyridine nucleotide-disulfide oxidoreductase, C46F11, both exhibiting 57% identity (Fig. 2). GR and C46F11 do not contain UGA selenocysteine codons and do not correspond in their predicted sizes to the 58-kDa protein identified by 75Se labeling. The predicted molecular masses of GR and C46F11 are 55 and 51.5 kDa, respectively.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Identification of the 58-kDa protein as a human thioredoxin reductase homologue by Western analysis. Western analysis of 75Se-labeled C. elegans homogenates with an antibody against human TRR. Following Western analysis the membrane was washed extensively with phosphate-buffered saline, dried, and autoradiographed. The major band in the 75Se labeling lane and the middle band in the hTRR antibody lane (arrow) are superimposable, indicating that they likely originate from the same protein. The bacterial selenoproteins are barely detectable in this experiment, presumably due to exhaustion of the food source.

Identification of a Putative SECIS Element in C. elegans TRR-- We next searched the sequence of the C. elegans TRR 3'-UTR for a potential SECIS element. Although there are several "AUGA" motifs in the 3'-UTR, none appeared in the context of a SECIS element. However, by extending the search to sequences which are similar but not identical to this motif, we identified a putative SECIS element that deviates from the vertebrate consensus by one nucleotide. The worm element, beginning with "GUGA" instead of "AUGA", is predicted to fold like a vertebrate form 2 SECIS element with a characteristic 10-base pair stem, an adenosine bulge, and an upper stem and small terminal loop (Fig. 4).


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 4.   Predicted structure of the C. elegans thioredoxin reductase SECIS element. Watson-Crick base pairing is indicated by lines and non-Watson Crick base pairing by ovals. Nucleotides conserved in other eukaryotic SECIS elements are shown in bold. Note that the SECIS element starts with a GUGA sequence instead of the AUGA consensus sequence. The G to A mutation introduced in construct CB151 that disrupts the GA quartet is indicated by the arrow.

The C. elegans TRR SECIS Element Is Functional in Mammalian Cells-- To investigate the ability of this putative SECIS element to direct selenocysteine incorporation in a mammalian cell line, we generated a construct containing the TRR SECIS element linked to the rat D1 coding region. This construct was transiently transfected into the human embryonic kidney-derived cell line HEK-293, and production of deiodinase activity was assessed. We have shown previously that a functional SECIS element is required for incorporation of selenocysteine into this protein, which in turn is required for maximal deiodinase activity (21) (18). The putative C. elegans SECIS element directed selenocysteine incorporation at an activity level slightly higher (134 ± 1.6%) than the wild type rat D1 SECIS element. Mutation of the invariant "G," the third nucleotide in the "AUGA" motif, in either the rat glutathione peroxidase or rat D1 SECIS elements was shown previously to reduce activity to ~6% (22) or to undetectable levels (3) (17), respectively. In the C. elegans SECIS element, this "G" to "A" mutation (Fig. 4) also resulted in near complete inactivation (3% of rat D1).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In this study, we report identification of the first selenoprotein and the first SECIS element in C. elegans. The protein migrates with the apparent molecular weight of a thioredoxin reductase homologue in the sequence data base and exhibits antibody cross-reactivity with members of this family of enzymes. Blast searches against the genome sequence of C. elegans (1998 number 85) using the protein sequences of all known vertebrate selenoproteins revealed the TRR sequence to be the only homologue of a vertebrate selenoprotein with a UGA codon at the corresponding position (Fig. 2). It has been speculated that this C. elegans homologue might be a selenoprotein based on the presence of the conserved UGA codon (23). Herein, we provide experimental evidence supporting the identity of the major C. elegans selenoprotein as TRR by Western analysis of 75Se-labeled C. elegans homogenates and autoradiography of the same membrane, allowing superimposition of the two films. Our labeling studies indicate that this protein is by far the most prominent selenoprotein in C. elegans. In addition to the putative TRR homologue, a 75Se-labeled band migrating at ~40 kDa was detected with varying intensity in different labeling experiments. The identity and source of this band are unknown; it may represent a degradation product derived from proteolysis of either the putative worm TRR or one of the bacterial selenoproteins.

All vertebrate selenoproteins contain at least one SECIS element, which is required for decoding UGA as a selenocysteine codon. An "AUGA" motif within the structural context of a SECIS element is invariant in all previously characterized eukaryotic selenoprotein sequences. Only after searching for SECIS-like structures, while allowing for deviations from the consensus, did we identify a putative stem loop structure meeting the requirements of a form 2 SECIS element. In this SECIS element, a "GUGA" motif is present instead of "AUGA". This sequence still allows formation of the "GA quartet" shown recently to be critical for SECIS function in vertebrates (3). More importantly, the C. elegans TRR SECIS element directs selenocysteine incorporation in a mammalian cell line. Finally, a point mutation disrupting the ability to form the "GA quartet" resulted in near complete loss of activity, consistent with this element functioning analogously to mammalian SECIS elements. This suggests that the mechanism of selenocysteine incorporation may be evolutionarily conserved in eukaryotes.

It is not known whether the "GUGA" motif is specific for nematodes. The existence of an expressed sequence tag clone from the filarial nematode Onchocerca volvulus encoding a TRR homologue with a UGA codon at the corresponding position (GenBankTM accession number AA680606) suggests that in this subspecies TRR is also a selenoprotein. The sequence of the 3'-UTR, which would allow the search for a SECIS element in this gene, remains to be determined.

Since the genome of C. elegans has been completely sequenced, this sequence information could lead to the identification of components of the translational machinery required for selenoprotein synthesis. The genome of C. elegans contains selenocysteyl-tRNA (Sel C) and selenophosphate synthetase (Sel D) genes, the only two components of the selenoprotein translational machinery identified in eukaryotes to date. Interestingly, whereas Drosophila and humans have two forms of selenophosphate synthetase (Sel D), one form being itself a selenoprotein, C. elegans has only one (Y45F10A.4, GenBankTM accession number 3880988). This Sel D homologue exhibits similarity to both Sel D type 1 (50% identity) and type 2 (52% identity), but contains a cysteine codon at the position corresponding to Sec 63 in human Sel D type 2. A partial cDNA sequence from another filarial nematode, Brugia malayi indicates the presence of a cysteine-containing Sel D homologue (GenBankTM accession number AA585621).

Glutathione peroxidase (GPX) is a selenoenzyme in vertebrates, but in C. elegans, as well as in the filarial nematodes Dirofilaria immiti and Brugia phalangi, the homologues to GPX contain cysteine residues substituted for selenocysteine in the active site. The Dirofilaria immiti version of GPX exhibits a low level GPX activity compared with selenocysteine-containing GPX, when expressed in a bacterial expression system (24). This might indicate that in evolutionary terms it is more important to have a highly active, selenocysteine-containing TRR than a highly active GPX, providing the selective pressure to maintain the translational machinery required for selenoprotein synthesis.

Since the genome of Saccharomyces cerevisiae does not contain genes for selenocysteyl-tRNA or selenophosphate synthetase, and no selenoproteins have been identified experimentally in yeast, genetic studies of selenoprotein synthesis in eukaryotes have not been feasible to date. C. elegans could thus provide a long awaited model system for genetic dissection of this process in higher organisms. The technique of RNA-mediated interference in C. elegans and the facility of generating transgenic worms offer powerful approaches for studying selenoprotein synthesis, as well as the functions of this important redox protein in basal cellular processes and in development.

    ACKNOWLEDGEMENTS

Thanks go to Martin Viktor (Harvard Medical School, Boston, MA) for advice on C. elegans culture techniques, to Y. Kohara (National Institute of Genetics, Mishima, Japan) for promptly providing the expressed sequence tag clone to Manusha Ujwal for help with the alignment (Harvard Medical School, Boston, MA), and to John Gasdaska (Arizona Cancer Center, Tucson, AZ) for human TRR antiserum.

    Note Added in Proof

While this manuscript was in review, a publication describing 75Se labeling and partial purification of the C. elegans thioredoxin reductase appeared in press (25).

    FOOTNOTES

* This work was supported by the Reimar Luest grant from the Koerber Foundation (to C. B.) and by National Institutes of Health Grants DK47320 and DK 52963 (to M. J. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF162693.

Dagger To whom correspondence and reprint requests should be addressed: Thyroid Division, Dept. of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115. Tel.: 617-525-5153; Fax: 617-731-4718; E-mail: berry@rascal.med.harvard.edu.

    ABBREVIATIONS

The abbreviations used are: SECIS, selenocysteine insertion sequence; D1, type 1 deiodinase; GPX, glutathione peroxidase; GR, glutathione reductase; PAGE, polyacrylamide gel electrophoresis; PCR, polymerase chain reaction; TR, thioredoxin; TRR, thioredoxin reductase; UTR, untranslated region.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Low, S. C., and Berry, M. J. (1996) Trends Biochem. Sci. 21, 203-208[CrossRef][Medline] [Order article via Infotrieve]
2. Berry, M. J., Banu, L., Harney, J. W., and Larsen, P. R. (1993) EMBO J. 12, 3315-3322[Medline] [Order article via Infotrieve]
3. Martin, G. W., III, Harney, J. W., and Berry, M. J. (1998) RNA (N. Y.) 4, 65-73[Abstract]
4. Martin, G. W., III, Harney, J. W., and Berry, M. J. (1996) RNA (N. Y.) 2, 171-182[Abstract]
5. Bosl, M. R., Takaku, K., Oshima, M., Nishimura, S., and Taketo, M. M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 5531-5534[Abstract/Free Full Text]
6. Ho, Y. S., Magnenat, J. L., Bronson, R. T., Cao, J., Gargano, M., Sugawara, M., and Funk, C. D. (1997) J. Biol. Chem. 272, 16644-16651[Abstract/Free Full Text]
7. Matsui, M., Oshima, M., Oshima, H., Takaku, K., Maruyama, T., Yodoi, J., and Taketo, M. M. (1996) Dev. Biol. 178, 179-185[CrossRef][Medline] [Order article via Infotrieve]
8. Gasdaska, P. Y., Gasdaska, J. R., Cochran, S., and Powis, G. (1995) FEBS Lett. 373, 5-9[CrossRef][Medline] [Order article via Infotrieve]
9. Gladyshev, V. N., Jeang, K. T., and Stadtman, T. C. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6146-6151[Abstract/Free Full Text]
10. Gasdaska, P. Y., Berggren, M. M., Berry, M. J., and Powis, G. (1999) FEBS Lett. 442, 105-111[CrossRef][Medline] [Order article via Infotrieve]
11. Lee, S. R., Kim, J. R., Kwon, K. S., Yoon, H. W., Levine, R. L., Ginsburg, A., and Rhee, S. G. (1999) J. Biol. Chem. 274, 4722-4734[Abstract/Free Full Text]
12. Miranda-Vizuete, A., Damdimopoulos, A. E., Pedrajas, J. R., Gustafsson, J. A., and Spyrou, G. (1999) Eur. J. Biochem. 261, 405-412[Medline] [Order article via Infotrieve]
13. Gromer, S., Wissing, J., Behne, D., Ashman, K., Schirmer, R. H., Flohe, L., and Becker, K. (1998) Biochem. J. 332, 591-592
14. Nordberg, J., Zhong, L., Holmgren, A., and Arner, E. S. (1998) J. Biol. Chem. 273, 10835-10842[Abstract/Free Full Text]
15. Lee, B. J., Rajagopalan, M., Kim, Y. S., You, K. H., Jacobson, K. B., and Hatfield, D. (1990) Mol. Cell. Biol. 10, 1940-1949[Abstract/Free Full Text]
16. Mandel, S. J., Berry, M. J., Kieffer, J. D., Harney, J. W., Warne, R. L., and Larsen, P. R. (1992) J. Clin. Endocrinol. Metab. 75, 1133-1139[Abstract]
17. Buettner, C., Harney, J. W., and Larsen, P. R. (1998) J. Biol. Chem. 273, 33374-33378[Abstract/Free Full Text]
18. Berry, M. J., Maia, A. L., Kieffer, J. D., Harney, J. W., and Larsen, P. R. (1992) Endocrinology 131, 1848-1852[Abstract]
19. Heider, J., Baron, C., and Bock, A. (1992) EMBO J. 11, 3759-3766[Medline] [Order article via Infotrieve]
20. Gladyshev, V. N., Jeang, K. T., Wootton, J. C., and Hatfield, D. L. (1998) J. Biol. Chem. 273, 8910-8915[Abstract/Free Full Text]
21. Berry, M. J., Kieffer, J. D., Harney, J. W., and Larsen, P. R. (1991) J. Biol. Chem. 266, 14155-14158[Abstract/Free Full Text]
22. Walczak, R., Carbon, P., and Krol, A. (1998) RNA (N. Y.) 4, 74-84[Abstract]
23. Hatfield, D. L., Gladyshev, V. N., Park, J., Park, S. I., Chittum, H. S., Baek, H. J., Carlson, B. A., Yang, E. S., Moustafa, M. E., and Lee, B. J. (1999) Compr. Nat. Prod. Chem. 4, 353-380
24. Tripp, C., Frank, R. S., Selkirk, M. E., Tang, L., Grieve, M. M., Frank, G. R., and Grieve, R. B. (1998) Exp. Parasitol. 88, 43-50[CrossRef][Medline] [Order article via Infotrieve]
25. Gladyshev, V. N., Krause, M., Xu, X. M., Korotkov, K. V., Kryukov, G. V., Sun, Q. A., Lee, B. J., Wootton, J. C., and Hatfield, D. L. (1999) Biochem. Biophys. Res. Commun. 259, 244-249[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GENES CELLSHome page
C. Jee, L. Vanoaica, J. Lee, B. J. Park, and J. Ahnn
Thioredoxin is related to life span regulation and oxidative stress response in Caenorhabditis elegans
Genes Cells, December 1, 2005; 10(12): 1203 - 1210.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Taskov, C. Chapple, G. V. Kryukov, S. Castellano, A. V. Lobanov, K. V. Korotkov, R. Guigo, and V. N. Gladyshev
Nematode selenoproteome: the use of the selenocysteine insertion system to decode one codon in an animal genome?
Nucleic Acids Res., April 20, 2005; 33(7): 2227 - 2238.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Krnajski, T.-W. Gilberger, R. D. Walter, A. F. Cowman, and S. Muller
Thioredoxin Reductase Is Essential for the Survival of Plasmodium falciparum Erythrocytic Stages
J. Biol. Chem., July 12, 2002; 277(29): 25970 - 25975.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. V. Korotkov, S. V. Novoselov, D. L. Hatfield, and V. N. Gladyshev
Mammalian Selenoprotein in Which Selenocysteine (Sec) Incorporation Is Supported by a New Form of Sec Insertion Sequence Element
Mol. Cell. Biol., March 1, 2002; 22(5): 1402 - 1411.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Fagegaltier, A. Lescure, R. Walczak, P. Carbon, and A. Krol
Structural analysis of new local features in SECIS RNA hairpins
Nucleic Acids Res., July 15, 2000; 28(14): 2679 - 2689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. V. Kryukov, V. M. Kryukov, and V. N. Gladyshev
New Mammalian Selenocysteine-containing Proteins Identified with an Algorithm That Searches for Selenocysteine Insertion Sequence Elements
J. Biol. Chem., November 26, 1999; 274(48): 33888 - 33897.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Krnajski, T.-W. Gilberger, R. D. Walter, and S. Muller
Intersubunit Interactions in Plasmodium falciparum Thioredoxin Reductase
J. Biol. Chem., December 22, 2000; 275(52): 40874 - 40878.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S.-R. Lee, S. Bar-Noy, J. Kwon, R. L. Levine, T. C. Stadtman, and S. G. Rhee
Mammalian thioredoxin reductase: Oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity
PNAS, March 14, 2000; 97(6): 2521 - 2526.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buettner, C.
Right arrow Articles by Berry, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buettner, C.
Right arrow Articles by Berry, M. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.